Aerpio Pharmaceuticals, Inc.
HPTP-Beta inhibitors
Last updated:
Abstract:
Disclosed herein are compounds effective for activation of Tie-2 and inhibition of HPTP-beta. The compounds can provide effective therapy for conditions associated with angiogenesis, for example, ocular conditions. Formulations for increased solubility are disclosed.
Status:
Grant
Type:
Utility
Filling date:
7 May 2018
Issue date:
8 Dec 2020